These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17664489)

  • 1. Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.
    Zappasodi P; Dore R; Castagnola C; Astori C; Varettoni M; Mangiacavalli S; Lazzarino M; Corso A
    J Clin Oncol; 2007 Aug; 25(22):3380-1. PubMed ID: 17664489
    [No Abstract]   [Full Text] [Related]  

  • 2. Bortezomib-induced Sweet syndrome.
    Knoops L; Jacquemain A; Tennstedt D; Theate I; Ferrant A; Van den Neste E
    Br J Haematol; 2005 Oct; 131(2):142. PubMed ID: 16197442
    [No Abstract]   [Full Text] [Related]  

  • 3. Bortezomib-induced acute pancreatitis in a patient with multiple myeloma.
    Wang HH; Tsui J; Wang XY; Liu SS; Li J
    Leuk Lymphoma; 2014 Jun; 55(6):1404-5. PubMed ID: 23927397
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing bortezomib treatment in patients with relapsed multiple myeloma.
    Richardson P
    Clin Adv Hematol Oncol; 2006 May; 4(5):4-5; discussion 8; suppl 13. PubMed ID: 16832859
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe pulmonary complications after bortezomib treatment for multiple myeloma: an unrecognized pulmonary vasculitis?
    Pitini V; Arrigo C; Altavilla G; Naro C
    Leuk Res; 2007 Jul; 31(7):1027-8. PubMed ID: 17134751
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperlipidemia in a myeloma patient after bortezomib treatment.
    Gozzetti A; Fabbri A; Defina M; Chitarrelli I; Bocchia M
    Leuk Res; 2010 Sep; 34(9):e250. PubMed ID: 20363499
    [No Abstract]   [Full Text] [Related]  

  • 7. Bortezomib increases survival of patients with relapsed multiple myeloma.
    Health News; 2005 Sep; 11(9):9. PubMed ID: 16211682
    [No Abstract]   [Full Text] [Related]  

  • 8. Bortezomib (velcade) for multiple myeloma.
    Med Lett Drugs Ther; 2003 Jul; 45(1161):57-8. PubMed ID: 12865865
    [No Abstract]   [Full Text] [Related]  

  • 9. Bortezomib for myeloma -- much ado about something.
    Dispenzieri A
    N Engl J Med; 2005 Jun; 352(24):2546-8. PubMed ID: 15958811
    [No Abstract]   [Full Text] [Related]  

  • 10. Bortezomib and bilateral herpes zoster.
    di Meo N; Bergamo S; Dondas A; Trevisan G
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(1):21-2. PubMed ID: 22584902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib-related colon mucositis in a multiple myeloma patient.
    Siniscalchi A; Tendas A; Ales M; Fratoni S; Cupelli L; Dentamaro T; Scaramucci L; Giovannini M; Caravita T; Santeusanio G; Niscola P; de Fabritiis P
    Support Care Cancer; 2009 Apr; 17(4):325-7. PubMed ID: 19172306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].
    Muta T; Nakanishi H; Yasunaga M; Senba S; Murakami H; Kan S; Ueda Y; Fujisaki T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):237-41. PubMed ID: 21368487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute enteritis in a multiple myeloma patient receiving bortezomib and spinal radiotherapy: case report.
    Mohiuddin MM; Harmon DC; Delaney TF
    J Chemother; 2005 Jun; 17(3):343-6. PubMed ID: 16038531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pancreatitis caused by bortezomib.
    Solakoglu T; Akyol P; Guney T; Dilek I; Atalay R; Koseoglu H; Akin E; Demirezer Bolat A; Buyukasik NS; Ersoy O
    Pancreatology; 2013; 13(2):189-90. PubMed ID: 23561979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sweet-like syndrome induced by bortezomib.
    Kolb-Mäurer A; Kneitz H; Goebeler M
    J Dtsch Dermatol Ges; 2013 Dec; 11(12):1200-2. PubMed ID: 23905772
    [No Abstract]   [Full Text] [Related]  

  • 16. Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myeloma.
    Cornelis T; Beckers EA; Driessen AL; van der Sande FM; Koek GH
    Clin Toxicol (Phila); 2012 Jun; 50(5):444-5. PubMed ID: 22462599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breathless on bortezomib.
    O'Riordan D; Houghton J; Chisholm R; O'Driscoll BR
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in clinical Medicine. Bortezomib-induced skin lesions.
    Agterof MJ; Biesma DH
    N Engl J Med; 2005 Jun; 352(24):2534. PubMed ID: 15958809
    [No Abstract]   [Full Text] [Related]  

  • 19. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.
    Ozkurt ZN; Sucak GT; Aki SZ; Yağci M; Erdem O
    Cutan Ocul Toxicol; 2009; 28(3):141-3. PubMed ID: 19548772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib and bone health in adults: can we extend these findings to children?
    Eriksson E; Sävendahl L; Zaman F
    Eur J Haematol; 2013 Jun; 90(6):533-4. PubMed ID: 23489140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.